|
|
|
License Approval: Pharmaceuticals |
|
|
|
Our Challenge: To
acheive timely renewal of our client's license
to sell its imported serum products in China
- Client: "BioPharmaCo", a medium-sized European
bio-pharmaceutical company
- Our Mission: To develop and implement
a results-oriented government communications
strategy that would result in our client
receiving approval to import its products
in China. When we were hired, the client's
application had already been rejected, and
they needed us to understand why and
fix the situation.
- Obstacles
- Regulatory complications
- Recent transfer for regulatory responsibilities
to new government bodies greatly slowed
the processing of application renewals.
During the regulatory reshuffling,
regulators misplaced crucial documentation.
Miscommunication among regulators
- such as lost documentation -
was among the reasons BioPharmaCo's
application was rejected.
- Due to fears of HIV transmission,
regulators were uncertain if the serum
products in question were suitable
for import.
- Threats to client
- No guarantee how long registration
renewal would take
- Possibility that renewal would be
rejected outright and a lengthy reapplication
process - including new clinical trials
- would be required
- Possibility that even after reapplication,
the import would be forbidden
Our Integrated Approach: Developed and implemented
a government communications strategy based on
in-depth reserach
- Industry Intelligence: Conducted
a policy & situation analysis to understand:
- Reforms of all related regulatory department
- Drug registration regulations
- Policies on imported pharmaceuticals
- Related laws and regulations
- Corporate Diplomacy: Targets identification
- the key government and industry stakeholders
- Old industry regulator (Ministry of
Health)
- Newly-established regulatory body (State
Drug Administration)
- Influential industry experts and opinion-leaders
- Corporate Diplomacy: Message Development
- Product meets the stringent stafety
requirements in the client's country
- Client's products have strong safety
records
Implementation: The government communications
strategy relied on facts gathered in the research
stage and on relationships built up over time
to effectively communicate with and influence
decision-makers
- Facilitated opinon-leaders & industry
experts (i.e. those outside the government)
to:
- Visit the client
- Know safety facts about the client's
products
- Understand the safety controls in the
client's country
- Report to regulators in China
- Participate in seminars & write
articles
- Coordinated government relation-based activities
- Meetings with top industry regulator
- Published an industry guidebook in cooperation
with top regulator
- Publicized industry news on-line in
co-operation with regulatory body
- Facilitated top industry regulator's
visit to the client
Results: A shortcut to approval
- With China Concept: BioPharmaCo succeeded
in renewing the license for its serum products
within 2.5 years, saving much effort and time.
- Without China Concept: On its own,
BioPharmaCo would have risked being refused
to register, or at the least would have invested
much more time and effort, including conducting clinical
trials in China, for its application.
This process could have taken up to 10 years
|
| |